Day: February 24, 2021

SOUTH SAN FRANCISCO, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the fourth quarter and full year ended December 31, 2020.Recent Highlights:Achieved total revenue of $58.6 million for the three months ended December 31, 2020, increasing 64% over prior year fourth quarterDelivered record full year revenue of $192.2 million, an increase of 51% compared with full year 2019 revenueProvided over 25,000 patient results in the fourth quarter and approximately 79,000 patient results in 2020Generated GAAP net loss of $3.5 million, non-GAAP net income of $4.3 million, and positive...

NORTON, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) — CPS Technologies Corporation (NASDAQ:CPSH) today announced revenues of $20.9 million and an operating profit of $914 thousand for the year ended December 26, 2020. This compares with revenues of $21.5 million and an operating loss of $597 thousand for the year ended December 28, 2019.For the quarter ending December 26, 2020, revenues were $4.2 million with an operating loss of $291 thousand. For the quarter ending December 28, 2019, revenues were $5.4 million with an operating profit of $367 thousand.Grant Bennett, President and CEO, said, “2020 was unique. As the year progressed, customer demand for our existing, higher volume products, particularly baseplates for traction power modules, declined each quarter because of the increasing effects of Covid-19.On the other hand, demand...

Daix (France), February 24, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS) and other diseases with significant unmet medical need, today announced that Frédéric Cren, Chairman, CEO and cofounder of Inventiva, will participate at three upcoming investor conferences in March 2021.The event details are as follows:Conference n°1: Credit Suisse Virtual 2021 London Global Healthcare ConferenceEvent type: One-on-one investor meetingsDate: Tuesday-Thursday, March 2-4, 2021Format: Virtual eventConference n°2: H.C. Wainwright Virtual Global Life Sciences ConferenceEvent type: Corporate presentation, fireside chat, one-on-one investor meetingsDate: Tuesday,...

Daix (France), le 24 février 2021 – Inventiva (Euronext Paris et Nasdaq : IVA), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par voie orale pour le traitement de la stéatohépatite non alcoolique (NASH), des mucopolysaccharidoses (MPS) et d’autres maladies avec un besoin médical non satisfait significatif, annonce aujourd’hui que Frédéric Cren, Président-directeur général et cofondateur d’Inventiva, participera à trois conférences investisseurs au cours du mois de mars 2021.Les détails des événements sont les suivants :Conférence n°1 : « Credit Suisse Virtual 2021 London Global Healthcare Conference »Type d’événement : Rendez-vous investisseursDate : Mardi-jeudi, 2-4 mars 2021Format : Evénement virtuelConférence n°2 : « H.C. Wainwright Virtual Global Life Sciences Conference »Type...

MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced the closing of its previously announced private placement of 2,564,000 shares of its common stock and accompanying warrants to purchase an aggregate of up to 2,564,000 shares of common stock at a combined purchase price of $4.55 per share and accompanying warrant. The warrants are exercisable immediately at an exercise price of $5.00 per share and expire five years from the date of issuance. Gross proceeds were approximately $11.7 million, before deducting placement agent fees and other offering...

TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2020 are now available at www.sedar.com and the Company’s website at www.dividend15.com. For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.dividend15.com. 

TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — New Commerce Split (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2020 are now available at www.sedar.com and the Company’s website at www.commercesplit.com.For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.commercesplit.com.Investor Relations: 1-877-478-2372Local: 416-304-4443www.commercesplit.cominfo@quadravest.com

TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Canadian Banc Corp. (“the Company”) announces that its annual financial statements and management report of fund performance for the year ended November 30, 2020 are now available at www.sedar.com and the Company’s website at www.canadianbanc.com.For further information, please contact Investor Relations at 416-304-4443, toll free at 1-877-4-Quadra (1-877-478-2372), or visit www.canadianbanc.com.

Roanoke, VA, Feb. 24, 2021 (GLOBE NEWSWIRE) — ROANOKE, VA, February 24, 2021 — Luna Innovations Incorporated (NASDAQ: LUNA) announced today it will report its fourth-quarter and full-year financial results for the period ended December 31, 2020 after the close of the stock market on Thursday, March 11, 2021.  Following the release, at 5 p.m. Eastern, Scott Graeff, President and Chief Executive Officer; Gene Nestro, Chief Financial Officer; Brian Soller, Senior Vice President and General Manager of the Lightwave Division; and James Garrett, Senior Vice President and General Manager of the Luna Labs Division will host a conference call to discuss the fourth-quarter and full-year 2020 earnings results.The investor conference call will be available via live webcast on the Luna website at www.lunainc.com under the tab “Investor...

TORONTO, Feb. 24, 2021 (GLOBE NEWSWIRE) — Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce that Big Pharma Split Corp. (the “Company”) will undertake an offering of Preferred Shares and Class A Shares of the Company. The offering will be led by BMO Capital Markets and will include CIBC World Markets Inc., and Scotia Capital Inc.The Preferred Shares will be offered at a price of $10.50 per Preferred Share to yield 4.80% and the Class A Shares will be offered at a price of $13.75 per Class A Share to yield 9.0%.The closing price on the TSX of each of the Preferred Shares and the Class A Shares on February 24, 2021 was $10.52 and $13.99, respectively.The net proceeds of the offering will be used to invest in an equally-weighted portfolio of ten issuers comprised of equity securities selected by Harvest from a universe...